210 related articles for article (PubMed ID: 9331011)
1. A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertension.
Andersson OK; Neldam S
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S63-4. PubMed ID: 9331011
[No Abstract] [Full Text] [Related]
2. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM
Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension.
Heuer HJ; Schöndorfer G; Högemann AM
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S55-6. PubMed ID: 9331008
[No Abstract] [Full Text] [Related]
4. [Angiotensin receptor antagonist for therapy of patients with hypertension].
Rakugi H; Ogihara T
Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effects of candesartan cilexetil, enalapril and placebo.
Franke H
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S61-2. PubMed ID: 9331010
[No Abstract] [Full Text] [Related]
6. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension.
Zanchetti A; Omboni S; Di Biagio C
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S57-9. PubMed ID: 9331009
[No Abstract] [Full Text] [Related]
7. Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group.
Gradman AH; Lewin A; Bowling BT; Tonkon M; Deedwania PC; Kezer AE; Hardison JD; Cushing DJ; Michelson EL
Heart Dis; 1999; 1(2):52-7. PubMed ID: 11720604
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
Lacourcière Y; Asmar R
Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
[TBL] [Abstract][Full Text] [Related]
9. The antihypertensive effect and tolerability of candesartan cilexetil, a new generation angiotensin II antagonist, in comparison with losartan.
Andersson OK; Neldam S
Blood Press; 1998 Jan; 7(1):53-9. PubMed ID: 9551878
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population.
McInnes GT; O'Kane KP; Jonker J; Roth J
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S75-80. PubMed ID: 9331015
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.
Sever P; Holzgreve H
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S69-73. PubMed ID: 9331014
[TBL] [Abstract][Full Text] [Related]
13. Candesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blocker.
Sever P
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S91-5. PubMed ID: 9331018
[TBL] [Abstract][Full Text] [Related]
14. Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatment.
Willemsen JM; Rabelink TJ; Boer P; Gaillard CA
J Hum Hypertens; 2004 Dec; 18(12):857-63. PubMed ID: 15361886
[TBL] [Abstract][Full Text] [Related]
15. Reducing cardiovascular morbidity and mortality in the elderly.
Trenkwalder P
Blood Press Suppl; 2000; 1():40-3. PubMed ID: 11059636
[TBL] [Abstract][Full Text] [Related]
16. Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension.
Bönner G; Fuchs W
Curr Med Res Opin; 2005 Jun; 21(6):935-40. PubMed ID: 15969893
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of candesartan cilexetil in special patient groups.
Trenkwalder P
Blood Press Suppl; 2000; 1():27-30. PubMed ID: 11059633
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
[TBL] [Abstract][Full Text] [Related]
19. Improving antihypertensive efficacy while maintaining placebo-like tolerability.
Sever PS
Blood Press Suppl; 2000; 1():19-22. PubMed ID: 11059631
[TBL] [Abstract][Full Text] [Related]
20. Achieving quality 24-h blood pressure control with candesartan cilexetil.
Meredith P
Blood Press Suppl; 2000; 1():23-6. PubMed ID: 11059632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]